Few expect a repeat of that nearly bear market reckoning. Still, August has a dubious track record for lackluster returns, ...

DOJ probes, vertical integration risks, shaky earnings quality, and fading investor trust despite strong headline profits ...

Health care stocks sank after the White House released letters asking big pharmaceutical companies to cut prices and make ...

With more than half of second quarter earnings reported and stocks near record highs, company results have reassured ...

Over the past 11 quarters (33 months), Warren Buffett has overseen: Altogether, Buffett has sold $177.431 billion more in ...

Wall Street has plenty of appetite for risk even without Fed rate cuts. Figma surged 250 percent in its trading debut ...

Stocks are slumping on Wall Street and Treasury yields are falling sharply after the government reported a sharp slowdown in ...

A rebound on Wall Street and in the dollar has not allayed investor concerns about the ability of U.S. assets to outperform ...

The biotech company reported second-quarter financial results on Friday ahead of market open, a day after announcing plans to ...

Ark Invest analysts say Tesla could be an $8.3 trillion company by 2029, and other Wall Street experts have also made ...

If you're looking to put cash into two fantastic biotech stocks that Wall Street seems particularly bullish on, there's one ...

This is the only U.S.-listed public company that's been paying a consecutive dividend for more than 200 years -- and you've ...